EGFR TKIs have been reported to cause immunogenic apoptosis of tumor cells (124), and subsequently releasing aberrant intracellular antigens and recruiting T cells via interferon-γ-induced major histocompatibility complex class I presentation (120). This evidence concerns the gene EGFR and neoplasm.